本頁面由Tiger Trade Technology Pte. Ltd.提供服務

VBI Vaccines, Inc. (CDA)

0.0005
0.0000
成交量:- -
成交額:- -
市值:1.43萬
市盈率:0.00
高:0.0005
開:0.0005
低:0.0005
收:0.0005
52周最高:0.0005
52周最低:0.0005
股本:2,868.23萬
流通股本:2,673.45萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-4.2957
每股收益(LYR):-6.0261
淨資產收益率:-419.59%
總資產收益率:-29.15%
市淨率:-0.00
市盈率(LYR):0.00

資料載入中...

2025/01/03

重要事件披露

Form 8-K - Current report
2025/01/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/01/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/01/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/01/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/01/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/12/11

重要事件披露

Form 8-K - Current report
2024/09/06

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/08/02

重要事件披露

Form 8-K - Current report
2024/07/30

重要事件披露

Form 8-K - Current report
2024/06/25

重要事件披露

Form 8-K - Current report
2024/05/29

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/01

重要事件披露

Form 8-K - Current report
2024/04/17

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/04/16

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/11

重要事件披露

Form 8-K - Current report